Molecular mechanisms of resistance to antibiotics in Bartonella bacilliformis
Author(s) -
Silpak Biswas,
Didier Raoult,
JeanMarc Rolain
Publication year - 2007
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkm105
Subject(s) - microbiology and biotechnology , biology , antibiotics , erythromycin , rifampicin , ciprofloxacin , quinolone , aminoglycoside , dna gyrase , antibacterial agent , nalidixic acid , genetics , gene , escherichia coli
Bartonella bacilliformis is the aetiological agent of Carrion's disease. Although ciprofloxacin, rifampicin and erythromycin have been successfully used in the treatment of the disease, failures and relapses have been reported. The objective of our study was to select in vitro mutants resistant to antibiotics in order to determine the frequency of mutations and to characterize the mechanism of resistance at the molecular level.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom